Unibest
← Back to patent-cliff list

CAS 85-41-6

Phthalimide1,3-Dihydro-1,3-dioxoisoindole

Codes: Ambroxol- 036, Mosapride Citrate-022

Application context (from source-drug indications)

Chronic bronchitisRoxithromycin/Ambroxol HydrochlorideBronchitisRoxithromycin/Ambroxol HydrochlorideRespiratory tract infectionRoxithromycin/Ambroxol HydrochloridePneumoniaRoxithromycin/Ambroxol HydrochlorideTracheitisRoxithromycin/Ambroxol HydrochlorideBacterial infectionRoxithromycin/Ambroxol HydrochlorideAnaesthesiaAmbroxol HydrochloridePharyngitisAmbroxol HydrochlorideRespiratory diseaseAmbroxol HydrochlorideBronchitisAmbroxol HydrochlorideParkinson's diseaseAmbroxol HydrochlorideParkinsonismAmbroxol HydrochlorideGastritisMosapride CitrateEnteral feeding intoleranceMosapride CitrateIrritable bowel syndromeMosapride CitrateDyspepsiaMosapride CitrateConstipationMosapride Citrate

Source drugs (routes using this intermediate)

DrugTierExpiry
Roxithromycin/Ambroxol HydrochlorideTier C — Watch / trade-
Ambroxol HydrochlorideTier C — Watch / trade-
Mosapride CitrateTier C — Watch / trade-

Position in synthesis routes (up/downstream chain)

Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.

Roxithromycin/Ambroxol HydrochlorideOptimised routesteps: 3total yield: 10.9g(Ambroxol- 037)
Ambroxol HydrochlorideOptimised routesteps: 3total yield: 10.9g(Ambroxol- 037)
Mosapride CitrateOptimised routesteps: 6total yield: /

Intermediates available on this site

No listed intermediates for this target yet — send an RFQ directly and it will enter our matching pool.

This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.